Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
08/2005
08/31/2005CN1660435A New drug combinations
08/31/2005CN1660431A Combination of medication containing reductase inhibitor HMG CoA and Melatonin
08/31/2005CN1660427A Extracorporeal photopheresis in combination with anti-tnf treatment
08/31/2005CN1660423A Monoclonal antibody of distinguished membrane protein for anti lipocyte in use for reducing deposition of subcutaneous fat in pigs
08/31/2005CN1660420A Compound combination of Chinese traditional medicine in use for lowering viscosity of whole blood, thrombolysis and reducing blood fat
08/31/2005CN1660416A Method and application of preparing oral powder of insulin through microcapsule technique
08/31/2005CN1660407A Liquid preparation containing penta peptide of thymus and preparing method
08/31/2005CN1660406A Short peptide type nutriend emulsion inside bowel and producing method
08/31/2005CN1660393A Health products of anti fatigue, decreasing blood pressure and blood fat, against cancer and cancer preyention, and preparing method
08/31/2005CN1660390A Medication and health food in use for lowering blood sugar, improving function of intestinal tract and reducing platelet aggergation
08/31/2005CN1660388A Oral Chinese material medica preparation for regulating blood sugar and improving immunologic function and preparation method
08/31/2005CN1660385A Chewing tablets of 'Zhibituo' for treating hyperlipemia and preparation method
08/31/2005CN1660360A Preparation from natural products for nourishing the liver and preparing method
08/31/2005CN1660358A Fleece-flower root drop pills for prolonging life
08/31/2005CN1660352A Combination of medication of possessing synergetic effect
08/31/2005CN1660339A 'Sanxiaoling' capsule
08/31/2005CN1660329A Medication of possessing effect for reducing fat and treating fatty liver
08/31/2005CN1660321A Medicinal preparation of extractive from compound aspirin and rice fermentred with red yeast
08/31/2005CN1660304A Medication for reducing blood fat and preparation method
08/31/2005CN1660294A Application of barbat skullcap in preparing medication for treating diabetes
08/31/2005CN1660287A Capsule for descend of blood fat and preparing method
08/31/2005CN1660272A Oral combination of possessing effect for reducing blood fat
08/31/2005CN1660263A 'Qizhi' flumamine and preparation method
08/31/2005CN1660257A Soft capsule of extractive from leaves of persimmon and self-emulsifying system for releasing drug
08/31/2005CN1660245A Chinese material medica preparation for treating diabetes
08/31/2005CN1660244A Tea of reducing weight and blood fat, and preparation method
08/31/2005CN1660242A Combination for restraining p38 subfanmily of protein kinase activated by mitogen and application
08/31/2005CN1660240A Extermal weight reduction drug through adjusting incretion
08/31/2005CN1660236A Preparing tablets of reducing blood fat
08/31/2005CN1660235A Medication for treating diabetes
08/31/2005CN1660227A Capsule of dual gen-sengs and preparing technique
08/31/2005CN1660215A Medication for treating diabetes
08/31/2005CN1660212A Oral preparation of Chinese traditional medicine of possessing function of adjusting blood sugar, and preparing method
08/31/2005CN1660207A Preparation of health care for reducing blood fat and cholesterol, and producing method
08/31/2005CN1660153A Oral liquid for reviving nerve
08/31/2005CN1660145A New method for preparing injection of freeze-dried powder blood dredge
08/31/2005CN1660140A Activity combination of marine life and application
08/31/2005CN1660138A Natural medicine for treating osteopathia high blood pressure and diabetes etc. dozens of diseases
08/31/2005CN1660137A Calcium with biological activity in use for pharmacy and food additive, and preparation method
08/31/2005CN1660120A Injection of sodium phosphate ribvoflavin and preparation technique
08/31/2005CN1660119A Liposome combination of precursor of vitamine D3 and preparation method
08/31/2005CN1660111A Highly selective norepinephrine reuptake inhibitors and methods of using the same
08/31/2005CN1660110A Highly selective norepinephrine reuptake inhibitors and methods of using the same
08/31/2005CN1660109A Highly selective norepinephrine reuptake inhibitors and methods of using the same
08/31/2005CN1660108A Highly selective norepinephrine reuptake inhibitors and methods of using the same
08/31/2005CN1660104A Enteric coated tablet of glipizide and preparation method
08/31/2005CN1660101A Compound medicinal preparation of ligustrazine of phosphoric acids and xylitol, and preparation method
08/31/2005CN1660100A Medication for treating diabetes and complication
08/31/2005CN1660080A Drop pills of vitamine EC and preparation method
08/31/2005CN1660075A Composite health protection medicine of soybean isoflavone of molecular coverture
08/31/2005CN1660064A Nage lieqin self-emulsifying system for releasing medicine
08/31/2005CN1660060A Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of hyperuricemia
08/31/2005CN1660057A Solid dispersion and preoral combination of glibenclamide and preparation method
08/31/2005CN1216890C Cyclipostins, method for their production and use of same
08/31/2005CN1216884C Dibenz [a.g] quinolizinium derivatives and salts thereof
08/31/2005CN1216873C Valsartan salts
08/31/2005CN1216869C Polymorphic crystalline forms of celecoxib
08/31/2005CN1216867C 2-amino-nicotinamide derivative sand their use as VEGF-receptor tyrosine kinase inhibitors
08/31/2005CN1216859C Comminuted form of (S)-2-ethoxy-3-[4-(2-{4-methane-sulfonyloxyphenyl} ethoxy) phenyl] propanoic acid
08/31/2005CN1216857C Aniline-derived ligands for thyroid receptor
08/31/2005CN1216856C Novel cyclocompound having cycloalkylene chain, prepn. method and pharmaceutical compositions contg. same
08/31/2005CN1216635C Composition and method for curing diabetes
08/31/2005CN1216613C Health-care product capable of regulating blood-lipid and its preparation method
08/31/2005CN1216602C Combination of lipoic acids and conjugated acids for treating diabetic disorders
08/31/2005CN1216598C 药物用途 Drug use
08/30/2005US6936715 Lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines
08/30/2005US6936691 Secreted protein HCE3C63
08/30/2005US6936636 5-[phenyl-tetrahydronaphthalene-2-yl dihydronaphthalen-2-yl and heteroaryl-cyclopropyl]-pentadienoic acid derivatives having serum glucose reducing activity
08/30/2005US6936622 they are phosphodiesterase (PDE) inhibitors useful for treament of allergic rhinitis, crohn's disease, ulcerative colitis, rheumatoid arthritis, bronchitis, bronchial asthma, COPD, ARDS, psoriasis, eczema, and combination thereof thereof.
08/30/2005US6936612 2-(Pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones
08/30/2005US6936606 Cyanoamido-containing heterocyclic compounds useful as reversible inhibitors of cysteine proteases
08/30/2005US6936600 Oxidoreductase enzyme inhibitors such as (R)-1-[4-(2-methyl-4-phenyl-5,8-dihydro-6H-pyrido[3,4-d]pyrimidin-7-yl)-pyrimidin-2-yl-ethanol, used as antidiabetic agents
08/30/2005US6936588 homogenizing water, fat, a nitrogen-containing component, and carbohydrate with the inclusion of isomaltulose, pasteurizing for 10-30 seconds at 135 degrees c and sterilizing
08/30/2005US6936468 Oligodeoxyribonucleotide having one or more NF- kappa B binding sites.
08/30/2005US6936452 Inhibitors of the inositol polyphosphate 5-phosphate SHIP2 molecule
08/30/2005US6936250 Polysaccharide encapsualted antigen
08/30/2005US6936248 Methods of inhibiting GPR-9-6 function
08/30/2005CA2336968C Quinoline derivatives
08/30/2005CA2103887C Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
08/25/2005WO2005077905A1 Fused-ring 4-oxopyrimidine derivative
08/25/2005WO2005077900A1 Bicyclic amide derivatives
08/25/2005WO2005077895A1 Thioamides and salts thereof and cytokine production inhibitors containing both
08/25/2005WO2005077887A1 Novel method of synthesis and novel crystalline form of agomelatine and pharmaceutical compositions containing said form
08/25/2005WO2005077400A1 Cysteine rich peptides for improving thiol homeostasis
08/25/2005WO2005077395A1 Physiologically active composition and process for producing the same
08/25/2005WO2005077390A1 Hypoglycemic agent, remedy/preventive for diabetes and proces for producing the same
08/25/2005WO2005077384A1 Lipase activity inhibitor containing high-molecular weight polyphenol fraction, tea extract and process for producing the same
08/25/2005WO2005077378A1 Method of preventing, medicating and/or treating hypocalcaemia of domestic mammal
08/25/2005WO2005062824A3 Anti-hypercholesterolemic compounds
08/25/2005US20050187285 administering anticholesterol agents to inhibit the induction of major histocompatibilty complex (MHC class II) expression by gamma-inteferon (IFN- gamma); treatment of autoimmune diseases
08/25/2005US20050187284 Integrin receptor inhibitors
08/25/2005US20050187282 Condensed indoline derivatives and their use as 5HT, in particular 5HT2c, receptor ligands
08/25/2005US20050187273 Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function
08/25/2005US20050187269 Benzimidazole derivative and use thereof
08/25/2005US20050187254 Methods, compounds, and compositions for reducing body fat and modulating fatty acid metabolism
08/25/2005US20050187220 Alleviating pain, treating a locomotive disorders, stress, depression, epilepsy, Alzheimer's disease, senile dementia, general cognitive dysfunction, drug and alcohol abuse, hypotension, hypertension, tinnitus, pruritus, defective hearing, anorexia, obesity; chemical synthesis
08/25/2005US20050187194 fructose 1,6-bisphosphatase (FBPase) inhibitors for diabetic complications, hyperlipidemia, hypertension, arteriosclerosis, macroangiopathy; 2-amino-5-isobutyl-4-{2-[5-(N,N'-bis((S)-1-ethoxycarbonyl)ethyl)phosphonamido]furanyl}thiazole
08/25/2005US20050187173 A method of delaying the onset of diabetes
08/25/2005US20050187143 Contains a surfactant and optionally a preservative, an isotonicizing agent, a buffer, and/or an excipient; has less than 04% by weight of zinc based on the insulin content of the formulation.
08/25/2005US20050187142 Contains a surfactant and optionally a preservative, an isotonicizing agent, a buffer, and/or an excipient; has less than 0.4% by weight of zinc based on the insulin content of the formulation.
1 ... 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 ... 1298